Clinical Trials Sponsored by Veniti

Total 209 results

Veniti

Withdrawn

VERITAS: An Evaluation of the Veniti Vidi Retrievable Inferior Vena Cava Filter System in Patients at Risk for Pulmonary Embolism (VERITAS)

Deep Vein Thrombosis | Pulmonary Embolus

New Zealand, Australia
Verici Dx

Recruiting

Validation of Genomic Immune-phenotyping Profiles to Predict Risk of Kidney Transplant Rejection

Kidney Transplant Rejection

United States, United Kingdom, Italy, France, Spain
Zenith Epigenetics

Enrolling by invitation

Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol

mCRPC

United States
Zenith Epigenetics

Withdrawn

Phase 1 Study Evaluating ZEN003365 in Relapsed/Refractory Lymphoproliferative Malignancies or Relapsed/Refractory AML

Acute Myeloid Leukemia | Lymphoproliferative Malignancies

United States
Zenith Epigenetics

Completed

A Study of ZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer

Metastatic Castration-Resistant Prostate Cancer

United States
Zenith Epigenetics

Completed

A Study of ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer

Metastatic Castration-Resistant Prostate Cancer

United States
Verity Pharmaceuticals Inc.

Not yet recruiting

Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC) (EVER)

Bladder Cancer | Urothelial Carcinoma Bladder | Bladder Cancer Recurrent | Neoplasm Recurrence | Urothelial Carcinoma Recurrent | Non-Invasive Bladder Urothelial Carcinoma
Istituto Oncologico Veneto IRCCS
Regione del Veneto (Italy)

Active, not recruiting

Risk-Based Breast Screening in Young Women (RIBBS)

Breast Neoplasms

Italy
Mediti Pharma Inc.

Terminated

A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression

Aggression | Dementia | Psychosis | Agitation | Alzheimer Dementia

United States, Canada
Senti Biosciences

Not yet recruiting

SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS

AML/MDS | CD33 Expressing Hematological Malignancies | FLT3 Expressing Hematological Malignancies
Istituto Oncologico Veneto IRCCS

Recruiting

OLIGOS: Impact of Treatment on Primary Tumour in Patients With Newly Diagnosed Oligometastatic Neoplasia of the Prostate (OLIGOS)

Oligometastatic Prostate Carcinoma

Italy
Istituto Oncologico Veneto IRCCS

Active, not recruiting

Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma (ZEBRA)

Renal Cell Carcinoma

Italy
Istituto Oncologico Veneto IRCCS

Completed

Epidemiological Features and Clinical Course of COVID -19 Infection in Cancer Patients: The Rovid Study

Solid Tumor, Adult

Italy
Istituto Oncologico Veneto IRCCS

Recruiting

ImmunoNutrition and Colorectal Adenocarcinoma Surgery - INCAS Study (INCAS)

Colorectal Adenocarcinoma

Italy
Istituto Oncologico Veneto IRCCS

Recruiting

Pure Florid and Pleomorphic Lobular Carcinoma in Situ of the Breast: Towards an Increasingly Uniform Management

Pleomorphic Lobular Breast Carcinoma in Situ | Breast Florid Lobular Carcinoma in Situ

Italy
Istituto Oncologico Veneto IRCCS

Completed

Regorafenib in Patients With Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS

Glioblastoma Multiforme

Italy
Istituto Oncologico Veneto IRCCS

Active, not recruiting

First-line Combination of Capecitabine and Oxaliplatin Plus Bevacizumab in Elderly Patients With Metastatic Colorectal Cancer (COBRA)

Elderly Metastatic Colorectal Cancer Patients

Italy
Istituto Oncologico Veneto IRCCS

Completed

CAlorie and Protein REstriction PROgram in Barrett's Esophagus Patients (CARE-PRO). (CARE-PRO)

Overweight and Obesity | Barrett's Esophagus
Istituto Oncologico Veneto IRCCS

Terminated

TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES) (TIMES)

Carcinoma, Small Cell

Italy
Istituto Oncologico Veneto IRCCS

Active, not recruiting

First Line Osimertinib in the Real World: an Inter-regional Prospective Study (FLOWER)

EGF-R Positive Non-Small Cell Lung Cancer

Italy
Istituto Oncologico Veneto IRCCS

Completed

Videoscopic Ilioinguinal Lymphadenectomy for Melanoma

Melanoma | Secondary Malignant Neoplasm of Lymph Node
Istituto Oncologico Veneto IRCCS

Completed

Psychological Counselling in Diagnostic Screening

Cancer
Senti Tech Ltd

Not yet recruiting

REMAP-WEST-FLARE - FLAg for Review Efficacy Investigation (REMAPWESTFLARE)

COPD

United Kingdom
Senti Tech Ltd

Unknown

Feasibility of Remote Evaluation and Monitoring of Acoustic Pathophysiological Signals With External Sensor Technology (REMAP-WEST-FEA)

Respiratory Disease

United Kingdom
Spanish Oncology Genito-Urinary Group

Completed

Epidemiological Study to Identify Prognosis and Predictive Biomarkers for Advanced or Metastatic Renal Cell Carcinoma (SOGANG)

Metastatic Renal Cell Carcinoma

Spain
Spanish Oncology Genito-Urinary Group

Terminated

Study With Pazopanib and Weekly Paclitaxel in Penile Carcinoma (PAZOPEN-SOGUG) (PAZOPEN-SOGUG)

Penile Squamous Cell Carcinoma Stage IV

Spain
Istituto Oncologico Veneto IRCCS
Bayer

Not yet recruiting

Regorafenib for Recurrent Grade 2 and 3 Meningioma (MIRAGE Trial) (MIRAGE)

Meningioma, Malignant

Italy
Medical College of Wisconsin
Versiti

Withdrawn

Whole Blood Collection From Individuals in the Convalescent Phase of SARS-CoV-2 Infection

COVID | Sars-CoV2
Spanish Oncology Genito-Urinary Group

Completed

Clinical Trial With Vinflunine as Maintenance Therapy in Metastatic Urothelial Cancer (MAJA)

Carcinoma, Transitional Cell

Spain
Spanish Oncology Genito-Urinary Group

Completed

Validation of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Prognostic Classification for Targeted Therapies (TKI/mTOR Inhibitors) in Second Line After First Line Treatment With Pazopanib (Spazo-2)

Metastatic Renal Cell Carcinoma

Spain
Spanish Oncology Genito-Urinary Group

Completed

Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma

Adrenocortical Carcinoma

Spain
Spanish Oncology Genito-Urinary Group

Completed

Sunitinib in Patients With Renal Cells Carcinoma Metastasic or Locally Avanced in Patients Not Candidates to Curative Previous Nefrectomy (SOGUG/0107)

Carcinoma Renal Cells

Spain
Spanish Oncology Genito-Urinary Group

Completed

Clinical Trial on the Mixture of G, C and S in Treatment of Patients With RCC (SOGUG-02-06)

Carcinoma, Renal Cell

Spain
Spanish Oncology Genito-Urinary Group

Active, not recruiting

Description of the Population With Genitourinary Tumors and COVID-19 (SOGUGCOVID)

Covid19 | Genito Urinary Cancer

Spain
Spanish Oncology Genito-Urinary Group

Completed

Spanish Retrospective Study to Evaluate the Efficacy and Safety of Targeted Therapies After Pazopanib as First-line Therapy (SPAZO)

Metastatic Renal Cell Carcinoma

Spain
Spanish Oncology Genito-Urinary Group

Completed

Study of Weekly Cabazitaxel for Advanced Prostate Cancer

Hormone Refractory Prostate Cancer

Spain
Spanish Oncology Genito-Urinary Group

Completed

Sorafenib and Radiotherapy in the Treatment of Invasive Bladder Cancer With Conservative Intent (SOGUG-07-01)

Bladder Cancer

Spain
Hospital Moinhos de Vento

Recruiting

Evaluation of an Active Surveillance Protocol for Prostate Cancer in the Brazilian Population

Prostate Cancer

Brazil
Hospital Moinhos de Vento

Terminated

Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections (OPTIMISE)

Sepsis | Gram-Negative Bacterial Infections | Bacteremia | Severe Infection | Bloodstream Infection | Acinetobacter Infections | Pseudomonas Aeruginosa | Human | Carbapenem-Resistant Enterobacteriaceae Infection | Carbapenem Resistant Bacterial Infection

Brazil
Hospital Moinhos de Vento

Active, not recruiting

Cohort Study for the Assessment of Long-term Impact of COVID-19 Among Mild COVID-19 Patients in Brazil

COVID-19 | Quality of Life | Disability Physical | Disabilities Mental

Brazil
Hospital Moinhos de Vento

Not yet recruiting

Evaluation of the Impact of Telemedicine in Pediatric Intensive Care Units

Adolescent | Telemedicine | Critical Care | Pediatric | Intensive Care Units, Pediatric
Hospital Moinhos de Vento

Not yet recruiting

Interventions for Enhancing Adherence to Syphilis Treatment and Follow-up: Study Protocol for the Health Information and Monitoring of Sexually Transmitted Infections (SIM) Randomized Controlled Trial (SIM)

Syphilis
Hospital Moinhos de Vento

Active, not recruiting

Cohort Study for the Assessment of Long-term Impact of COVID-19 Among Moderate and Severe COVID-19 Patients in Brazil

COVID-19 | Quality of Life | Disability Physical | Disabilities Mental

Brazil
Hospital Moinhos de Vento

Completed

Orientation Effects of Breastfeeding for Mothers

Breastfeeding

Brazil
Hospital Moinhos de Vento

Unknown

Pharmaceutical Care in Ambulatory Hemodialysis Patients

Medication Adherence | Renal Failure Chronic Requiring Hemodialysis | Chronic Renal Diseases

Brazil
Hospital Moinhos de Vento

Recruiting

Protocol For Sleep for Critically Ill Patients

Sleep Disorders

Brazil
Hospital Moinhos de Vento

Recruiting

Deflating the Tracheostomy Tube Cuff and Time for Decannulation

Deglutition Disorders | Tracheostomy Complication

Brazil
Hospital Moinhos de Vento

Not yet recruiting

Long-term Impact of COVID-19 Among COVID-19 Patients With Acute Respiratory Distress Syndrome in Brazil

COVID-19 | ARDS
Hospital Moinhos de Vento

Completed

Clinical Trial Comparing Carnoy's and GEWF Solutions

Colorectal Cancer | Lymph Node Metastasis

Brazil
Hospital Moinhos de Vento

Unknown

The Effects of Mechanical Insufflation-exsufflation on Airway Mucus Clearance in the ICU

Respiratory Failure

Brazil

Clinical Trials Sponsored by Veniti

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations